Literature DB >> 17927280

Recent advances in the pharmacological management of pain.

Josée Guindon1, Jean-Sébastien Walczak, Pierre Beaulieu.   

Abstract

Pain is an unpleasant sensation that originates from ongoing or impending tissue damage. Management of different types of pain (acute, postoperative, inflammatory, neuropathic or cancer) is the most frequent issue encountered by clinicians and pharmacological therapy is the first line of approach for the treatment of pain. This review presents and discusses recent clinical advances regarding both the improvements in delivery of analgesic drugs and improvements in the design of analgesic molecules. The new modalities of administration of analgesics used in the clinic are reviewed, including skin patches, oral and mucosal sprays, transdermal delivery systems and intranasal administration. New insights are then presented on standard drugs used to relieve pain, such as opioids (including tramadol), NSAIDs including selective cyclo-oxygenase-2 inhibitors, paracetamol (acetaminophen), local anaesthetics and adjuvant analgesics such as antidepressants, anticonvulsants (gabapentin and pregabalin), cannabinoids, ketamine and others (e.g. nefopam). Although the understanding of pain mechanisms has improved significantly recently, much more is yet to be discovered and awaited. Broadening of our knowledge is needed to improve basic and clinical research in this field in order to better alleviate pain in millions of people.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17927280     DOI: 10.2165/00003495-200767150-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  159 in total

1.  Infiltration with ropivacaine plus lornoxicam reduces postoperative pain and opioid consumption.

Authors:  Beyhan Karamanlioglu; Alparslan Turan; Dilek Memis; Gaye Kaya; Sanem Ozata; Mevlut Ture
Journal:  Can J Anaesth       Date:  2005-12       Impact factor: 5.063

2.  Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials.

Authors:  Nadia Elia; Christopher Lysakowski; Martin R Tramèr
Journal:  Anesthesiology       Date:  2005-12       Impact factor: 7.892

3.  Comparison between tramadol and pethidine in patient controlled intravenous analgesia.

Authors:  Faisal Shamim; Muhammad Qamarul Hoda; Khalid Samad; Salman Sabir
Journal:  J Pak Med Assoc       Date:  2006-10       Impact factor: 0.781

Review 4.  An iontophoretic, fentanyl HCl patient-controlled transdermal system for acute postoperative pain management.

Authors:  Jacques E Chelly
Journal:  Expert Opin Pharmacother       Date:  2005-06       Impact factor: 3.889

Review 5.  Continuous peripheral nerve blocks at home: a review.

Authors:  Brian M Ilfeld; F Kayser Enneking
Journal:  Anesth Analg       Date:  2005-06       Impact factor: 5.108

Review 6.  Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics.

Authors:  Kyriaki Mystakidou; Emmanuela Katsouda; Efi Parpa; Marinos L Tsiatas; Lambros Vlahos
Journal:  Am J Hosp Palliat Care       Date:  2005 May-Jun       Impact factor: 2.500

7.  Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.

Authors:  S H Sindrup; F W Bach; C Madsen; L F Gram; T S Jensen
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

8.  Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.

Authors:  M B Max; S A Lynch; J Muir; S E Shoaf; B Smoller; R Dubner
Journal:  N Engl J Med       Date:  1992-05-07       Impact factor: 91.245

9.  Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism.

Authors:  Gisèle Pickering; Marie-Anne Loriot; Frédéric Libert; Alain Eschalier; Philippe Beaune; Claude Dubray
Journal:  Clin Pharmacol Ther       Date:  2006-04       Impact factor: 6.875

10.  Spinal and Supraspinal sites for morphine and nefopam analgesia in the mouse.

Authors:  M F Piercey; L A Schroeder
Journal:  Eur J Pharmacol       Date:  1981-09-11       Impact factor: 4.432

View more
  18 in total

1.  Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice.

Authors:  Molly S Crowe; Emma Leishman; Matthew L Banks; Ramesh Gujjar; Anu Mahadevan; Heather B Bradshaw; Steven G Kinsey
Journal:  Br J Pharmacol       Date:  2015-01-20       Impact factor: 8.739

2.  Polymeric matrix system for prolonged delivery of tramadol hydrochloride, part II: biological evaluation.

Authors:  Hussein O Ammar; Mahmoud Ghorab; Soheir A El-Nahhas; Rabab Kamel
Journal:  AAPS PharmSciTech       Date:  2009-08-04       Impact factor: 3.246

Review 3.  The endocannabinoid system and pain.

Authors:  Josée Guindon; Andrea G Hohmann
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

Review 4.  The cannabinoid system and pain.

Authors:  Stephen G Woodhams; Victoria Chapman; David P Finn; Andrea G Hohmann; Volker Neugebauer
Journal:  Neuropharmacology       Date:  2017-06-15       Impact factor: 5.250

Review 5.  Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain.

Authors:  Henry L Blanton; Jennifer Brelsfoard; Nathan DeTurk; Kevin Pruitt; Madhusudhanan Narasimhan; Daniel J Morgan; Josée Guindon
Journal:  Drugs       Date:  2019-06       Impact factor: 9.546

6.  Concomitant facilitation of GABAA receptors and KV7 channels by the non-opioid analgesic flupirtine.

Authors:  Felicia Klinger; Petra Geier; Mario M Dorostkar; Giri K Chandaka; Arsalan Yousuf; Isabella Salzer; Helmut Kubista; Stefan Boehm
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

7.  Allosteric modulation model of the mu opioid receptor by herkinorin, a potent not alkaloidal agonist.

Authors:  A F Marmolejo-Valencia; K Martínez-Mayorga
Journal:  J Comput Aided Mol Des       Date:  2017-03-31       Impact factor: 3.686

8.  The antihyperalgesic effect of levetiracetam in an inflammatory model of pain in rats: mechanism of action.

Authors:  A Micov; M Tomić; B Popović; R Stepanović-Petrović
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 9.  Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain.

Authors:  J Guindon; A G Hohmann
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

10.  Different SNP combinations in the GCH1 gene and use of labor analgesia.

Authors:  Fatimah Dabo; Alfhild Grönbladh; Fred Nyberg; Inger Sundström-Poromaa; Helena Akerud
Journal:  Mol Pain       Date:  2010-07-15       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.